+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
MEDICAPS

MediCaps Share Price

 

 

MediCaps live price: ₹26.75. It opened at ₹28 vs previous close ₹28; intraday high/low: ₹29/₹27. The 50 & 200 DMA stand at ₹27.96/₹31.31.

MediCaps Performance

  • Today's Low
  • ₹27
  • Today's High
  • ₹29
  • 52 Week Low
  • ₹21
  • 52 Week High
  • ₹47
  • Open Price₹28
  • Previous Close₹28
  • Volume1,249
  • 50 DMA₹27.96
  • 100 DMA₹28.50
  • 200 DMA₹31.31

MediCaps Chart

Investment Returns

  • Over 1 Month -0.78%
  • Over 3 Month + 6.53%
  • Over 6 Month -17.64%
  • Over 1 Year -38.65%

Smart Investing Starts Here Start SIP with MediCaps for Steady Growth!

Invest Now

MediCaps Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -11
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 33
  • P/B Ratio
  • 0.3
  • Average True Range
  • 2.52
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.24
  • RSI
  • 44.23
  • MFI
  • 21.57

MediCaps Financials

MediCaps Technicals

EMA & SMA

Current Price
₹26.75
-0.83 (-3.01%)
  • Bearish Moving Average 0
  • Bullish Moving Average 0
  • 20 Day
  • ₹27.90
  • 50 Day
  • ₹28.00
  • 100 Day
  • ₹28.50
  • 200 Day
  • ₹31.30

Resistance and Support

27.53 Pivot Speed
  • R3 30.45
  • R2 29.68
  • R1 28.30
  • S1 26.15
  • S2 25.38
  • S3 24.00

MediCaps Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-21 Audited Results
2026-02-11 Quarterly Results
2025-11-12 Quarterly Results
2025-08-05 Quarterly Results
2025-05-21 Audited Results

MediCaps Shareholding Pattern

No data available.

MediCaps FAQs

MediCaps share price is ₹26 As on 20 June, 2026 | 06:48

The Market Cap of MediCaps is ₹33.4 Cr As on 20 June, 2026 | 06:48

The P/E ratio of MediCaps is -11 As on 20 June, 2026 | 06:48

The PB ratio of MediCaps is 0.3 As on 20 June, 2026 | 06:48

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23